1-3 of 3
Markus Ollert
Close
Sort by
Journal Articles

Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia

Marina Wierz, Sandrine Pierson, Léa Guyonnet, Elodie Viry, Audrey Lequeux, Anaïs Oudin, Simone P. Niclou, Markus Ollert, Guy Berchem, Bassam Janji, Coralie Guérin, Jerome Paggetti, Etienne Moussay
Journal: Blood
Blood (2018) 131 (14): 1617–1621.
https://doi.org/10.1182/blood-2017-06-792267
Published: 2018
Includes: Supplemental data
Journal Articles

Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain

Katharina Lückerath, Vladimir Kirkin, Inga Maria Melzer, Frederic B. Thalheimer, Dagmar Siele, Wiebke Milani, Thure Adler, Antonio Aguilar-Pimentel, Marion Horsch, Geert Michel, Johannes Beckers, Dirk H. Busch, Markus Ollert, Valerie Gailus-Durner, Helmut Fuchs, Martin Hrabĕ de Angelis, Frank J. T. Staal, Krishnaraj Rajalingam, Anne-Odile Hueber, Lothar J. Strobl, Ursula Zimber-Strobl, Martin Zörnig
Journal: Blood
Blood (2011) 117 (2): 519–529.
https://doi.org/10.1182/blood-2010-07-292722
Published: 2011
Includes: Supplemental data
Journal Articles

Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo

Heiko Pfister, Markus Ollert, Leopold F. Fröhlich, Leticia Quintanilla-Martinez, Thomas V. Colby, Ulrich Specks, Dieter E. Jenne
Journal: Blood
Blood (2004) 104 (5): 1411–1418.
https://doi.org/10.1182/blood-2004-01-0267
Published: 2004
Includes: Supplemental data